Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06388174
Status:
RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-16
Brief Title:
Idiopathic Generalized Epilepsy Syndromes
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Study Overview
Official Title:
Idiopathic Generalized Epilepsy Syndromes Clinical Features and Long-term Outcomes
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The idiopathic generalized epilepsies IGEs have historically included the syndromes childhood absence epilepsy CAE juvenile absence epilepsy JAE juvenile myoclonic epilepsy JME and epilepsy with generalized tonic-clonic seizures alone GTCA Recognition of the IGEs is important for clinical care as it informs diagnosis prevents unnecessary investigation allows optimal selection of anti-seizure medications ASMs and provides prognostic guidance
According to the new ILAE definition in 2022 the study aims to describe the clinical features electroencephalographic imaging findings and long-term prognosis
According to the new ILAE definition in 2022 the study aims to describe the clinical features electroencephalographic imaging findings and long-term prognosis
Detailed Description:
the Long-term prognosis include the rate of drug-resistent epilepsy relapse after drug withdrawn common comorbidities such as mood disorders attention deficit hyperactivity disorder ADHD and learning disabilities
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None